By Dr. Srivathsan V. Raghavan, DrPH

Prologue

Let’s talk about something most executives never think about until it’s a crisis: the workplace itself can cause cancer. Every year, thousands of American families get life-changing diagnoses that trace back to something as ordinary as a job site — a warehouse, a factory floor, a construction zone. The good news? Most of this is preventable. Workplace exposure to toxic substances is estimated to cause somewhere between 2% and 8% of cancers worldwide, and unlike genetics or bad luck, this is a risk factor companies can actually control (Loomis et al., 2018).

Cancer itself isn’t new — Hippocrates was describing tumors that looked like crabs (hence the name “cancer,” from the Greek word for crab) more than two thousand years ago (Panegyres, 2024). What has changed is our understanding of why cells go rogue in the first place. At the most basic level, cancer starts with damage to DNA — the four-letter code (A, T, G, C) that tells our cells how to behave. When that code is corrupted by substances such as asbestos fibers or benzene fumes, the internal “brakes” on cell division, such as the p53 gene, can fail, and cells start growing uncontrollably (Alberts et al., 2022; Nelson & Cox, 2021). This piece is written for anyone — executive, safety officer, or curious reader — who wants a clear, no-jargon walk-through of how workplace chemicals cause cancer, and what leadership can actually do about it.

The Critical Assessment

Here’s the part that should get every C-suite leader’s attention: occupational cancers take a long time to show up. We’re talking a 10-to-40-year gap between the day someone is exposed and the day they’re diagnosed (Loomis et al., 2018). That delay is exactly why so many companies underestimate the risk — the damage is invisible for decades, then it shows up as a lawsuit, a spike in insurance costs, or a grieving family. Four substances show up again and again in the research as the biggest offenders in American workplaces:

•  Asbestos — tiny mineral fibers linked to mesothelioma and lung cancer (Loomis et al., 2018).

•  Benzene — an industrial solvent that damages bone marrow and can trigger leukemia (Ward et al., 2010).

•  Crystalline silica dust — kicked up during cutting, sandblasting, and masonry work, and linked to lung scarring and tumors (Loomis et al., 2018).

•  Hexavalent chromium — used in electroplating and stainless steel work, tied to respiratory and sinus cancers (Loomis et al., 2018).

It’s also worth saying plainly: these risks aren’t spread evenly across a company. Lower-paid, physically demanding jobs tend to carry the heaviest exposure burden, which means the people with the least power to change their working conditions often carry the most risk (Collatuzzo et al., 2023). That’s not just an ethics problem — it’s a liability problem, since concentrated harm in one part of the workforce is exactly what class-action litigation is built on.

So what actually works? Public health researchers keep coming back to the same playbook: the Hierarchy of Controls, championed by NIOSH and OSHA. It’s a five-step ladder, ranked from most to least effective (Centers for Disease Control and Prevention, 2024; Occupational Safety and Health Administration, 2023):

1.  Elimination — remove the hazardous substance from the process entirely.

2.  Substitution — swap it for something less toxic.

3.  Engineering controls — ventilation systems, sealed equipment, physical barriers that isolate workers from the hazard.

4.  Administrative controls — job rotation, shorter shifts near the hazard, training programs.

5.  Personal protective equipment (PPE) — respirators, gloves, suits.

Here’s the catch: most workplaces default to the bottom of that ladder — handing out PPE — because it’s the cheapest, fastest fix. But PPE only works if it’s worn correctly every single time, and it does nothing to remove the hazard itself. Real prevention means climbing higher up the ladder: eliminating or substituting the dangerous chemical, or engineering the danger out of the process (Occupational Safety and Health Administration, 2023).

This isn’t just a compliance checkbox, either — it’s smart business. Companies that invest in real prevention see three concrete payoffs: fewer long-tail legal claims decades down the road, lower workers’ comp and insurance costs today, and better recruitment and retention because people want to work somewhere that doesn’t quietly put them at risk (Griswold et al., 2023). Forward-looking organizations are also starting to fold occupational health surveillance — things like routine screenings, biomarker testing, and lung scans — directly into their broader employee wellness programs, turning a compliance function into a genuine early-detection system (Collatuzzo et al., 2025).

In Conclusion

Cancer caused by workplace exposure is one of the rare types of cancer that’s largely within an organization’s control to prevent. The science is clear: substances like asbestos, benzene, silica dust, and hexavalent chromium damage DNA and trigger cancer, often decades before anyone notices a problem (Loomis et al., 2018; Ward et al., 2010). Because of that long delay between exposure and diagnosis, the true cost of ignoring workplace hazards doesn’t show up on this year’s balance sheet — it shows up ten or twenty years from now, as litigation, turnover, and reputational damage. The fix isn’t complicated in concept, even if it requires real investment: climb the Hierarchy of Controls, favor elimination and substitution over PPE, and build occupational health tracking into the company’s day-to-day operations (Centers for Disease Control and Prevention, 2024).

Call to Action

If you’re in a leadership seat — or you’re the person who has to convince leadership — here’s where to start:

1.  Get an independent industrial hygiene audit. You can’t fix what you haven’t mapped.

2.  Push elimination and substitution first. Don’t let PPE become the default answer.

3.  Fold occupational health screenings into your regular employee wellness benefits, not a separate, forgettable program.

4.  Invest in monitoring — wearable sensors and air-quality tracking catch problems before they become diagnoses.

5.  Report on it. Put exposure and health metrics in front of the board the same way you’d report on revenue or safety incidents.

Treating this as a strategic priority — not just a regulatory hurdle — protects your people, your budget, and your company’s future all at once. That’s a pretty good return on investment.

---

These are some products I discovered while searching for materials and tools that may help prevent certain types of occupational cancers. I follow the U.S. Federal Trade Commission’s (FTC) directive; therefore, I must state the FTC affiliate disclosure to ensure full legal compliance at the federal level. Thank you! ~ Dr. Srivathsan Raghavan, DrPH

---

FTC Affiliate Disclosure: This article contains affiliate links to products that support occupational health and safety. If you click on these links and make a purchase, I may earn a small commission at no additional cost to you. These recommendations are based on evidence‑informed safety practices and are provided to help readers identify tools that can reduce exposure to workplace carcinogens. All opinions expressed are my own, and affiliate partnerships do not influence the content, analysis, or recommendations presented in this post.

1. 3M Rugged Comfort Quick Latch Half Facepiece Respirator with P100 Filters: https://www.amazon.com/s?k=3M+Rugged+Comfort+Quick+Latch+Half+Facepiece+Respirator+P100&tag=drsrivathsanr-20 (amazon.com in Bing)
2. GVS Elipse P100 Half Mask Respirator: https://www.amazon.com/s?k=GVS+Elipse+P100+Half+Mask+Respirator&tag=drsrivathsanr-20 (amazon.com in Bing)
3. 3M 6800 Full Facepiece Respirator with P100 Filters: https://www.amazon.com/s?k=3M+6800+Full+Facepiece+Respirator+P100&tag=drsrivathsanr-20 (amazon.com in Bing)
4. 3M Versaflo TR‑600‑HIK Heavy Industry PAPR Kit: https://www.amazon.com/s?k=3M+Versaflo+TR-600-HIK+PAPR+Kit&tag=drsrivathsanr-20 (amazon.com in Bing)
5. TSI BlueSky Air Quality Monitor 8143: https://www.amazon.com/s?k=TSI+BlueSky+Air+Quality+Monitor+8143&tag=drsrivathsanr-20 (amazon.com in Bing)
6. 3M 4510 Disposable Protective Coveralls: https://www.amazon.com/s?k=3M+4510+Disposable+Protective+Coveralls&tag=drsrivathsanr-20 (amazon.com in Bing)
7. Honeywell Multipurpose Half Mask Respirator with P100 Filters: https://www.amazon.com/s?k=Honeywell+Multipurpose+Half+Mask+Respirator+P100&tag=drsrivathsanr-20 (amazon.com in Bing)

---

Dr. Srivathsan Raghavan is a researcher and practitioner dedicated to solving systemic vulnerabilities within industrial infrastructure. As a Doctor of Public Health, he emphasizes Occupational Health and Safety. He bridges translational science and large-scale corporate execution. Dr. Raghavan integrates rigorous academic theory with real-world operations management to analyze and mitigate environmental health threats. His writing provides evidence-based insights into HAZMAT RMP (Hazardous Materials Responsible Management Person) compliance, offering clinical, scientific, and administrative peers a clear view of how operational design directly affects workforce longevity, population health outcomes, and institutional risk.

References:

Alberts, B., Heald, R., Johnson, A., Morgan, D., Raff, M., Roberts, K., & Walter, P. (2022). Molecular biology of the cell (7th ed.). W. W. Norton & Company.

American Cancer Society. (n.d.). A brief history of cancer. https://www.cancer.org/cancer/understanding-cancer/history-of-cancer.html

Cancer Research UK. (n.d.). What is cancer? https://www.cancerresearchuk.org/about-cancer/what-is-cancer

Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health. (2024). Hierarchy of controls. https://www.cdc.gov/niosh/hierarchy-of-controls/about/index.html

Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health. (n.d.). Cancer (occupational). https://www.cdc.gov/niosh/cancer/about/index.html

Collatuzzo, G., Turati, F., Malvezzi, M., Negri, E., La Vecchia, C., & Boffetta, P. (2023). Attributable fraction of cancer related to occupational exposure in Italy. Cancers, 15(8), Article 2234. https://doi.org/10.3390/cancers15082234

Collatuzzo, G., Godono, A., Fiorini, G., Vencovsky, D., Giordani, S., Biagioli, V., Pinto-Vidal, F. A., Seyyedsalehi, M. S., Kostrzewa, M., Honrado, A., Bruno, D., Tardon, A., Mates, D., Schneider-Kamp, A., Fabianova, E., & Boffetta, P. (2025). Expanding cancer prevention: Strategies integrated into occupational health surveillance. Cancers, 17(21), Article 3535. https://doi.org/10.3390/cancers17213535

Griswold, M. G., Fullman, N., Hawley, C., Aravkin, A. Y., Culbreth, G. T., Biehl, M. H., et al. (2023). Global burden of neoplasms attributable to specific occupational carcinogens over 30 years: A population-based study. Public Health, 223, 115–125.

Loomis, D., Guha, N., Hall, A. L., & Straif, K. (2018). Identifying occupational carcinogens: An update from the IARC Monographs. Occupational and Environmental Medicine, 75(8), 593–603. https://doi.org/10.1136/oemed-2017-104944

Ni, J., & Zhang, L. (2020). Cancer cachexia: Definition, staging, and emerging treatments. Cancer Management and Research, 12, 5597–5605. https://doi.org/10.2147/CMAR.S261585

Nelson, D. L., & Cox, M. M. (2021). Lehninger principles of biochemistry (8th ed.). W. H. Freeman and Company.

Occupational Safety and Health Administration. (2023). Identifying hazard control options: The hierarchy of controls (Form 508_2). U.S. Department of Labor. https://www.osha.gov/sites/default/files/Hierarchy_of_Controls_02.01.23_form_508_2.pdf

Panegyres, K. (2024). The story of how cancer got its name. Cancer, 130(20), 3401–3403. https://doi.org/10.1002/cncr.35428